YTB Calls off LTS Merger

September 6, 2012 -- YTB International Inc. announced that it has ended merger discussions with LTS Neutraceuticals Inc. In a regulatory filing, YTB said that it "has determined that, after further analysis and consideration, a merger with LTS Neutraceuticals Inc. is not in the best long-term interests of the stockholders and would no enhance the strategic or competitive stance of the company."

YTB also announced that executive vice president and chairman J. Scott Tomer resigned his posts in the company as of August 31. A new chairman will be appointed at YTB's next board meeting.

 

More YTB News and Articles

• YTB International Files Chapter 11
• YTB Calls off LTS Merger
• YTB International Appoints Andrew Cauthen President and CEO
• YTB International CEO Resigns Amid Restructuring Program
• YTB International Announces Merger Agreement
• YTB Completes Travel Agreement
• YTB – ZamZuu to Market Energy
• YTB International Faces Illinois Pyramid Scheme Lawsuit
• YTB Faces Court Action
• YTBTravel Mentioned in ASTA Article
• Insider Deals at YTB Raise Questions, Concerns
• Brown Sues to Topple YTB
• California AG Files for Injunction Against YTB
• YTB Travel Considers Dropping Network Marketing Model
• YTB Named in Travel Weekly Power List
• YTB refutes negative images, emphasizing multilevel biz model
• YTB International Announces Removal from OTC

 

YTB Profile

Create a Free YTB Rep Listing